维普中文期刊产品整合服务
27篇 您的检索式:作者名="Barok M"
    题名 作者 年代 出处 被引量
1Trastuzumab-DM1 causes- tumour growth inhibition by mitotic catastrophe in trasmzumab-re- sistant breast cancer cells in vivo显示文摘Barok M Tanner M Koninki K 2011Breast Cancer Res2011,13,2:1
2Trastuzumab decreases the number of circulating and disseminated tumor cells despite trastuzumab resistance of the primary tumor显示文摘Barok M Balazs M Nagy P 2008Cancer Lett2008,260,12:1
3ErbB-directed im?munotherapy: antibodies in current practice and promising new agents显示文摘Friedlander E Barok M SzollosiJ 2008Immunol Lett2008,116,:1
4Trastuzumab-DM1 causes tumour growth inhibition by mitotic catastrophe in trastuzumab-resistant breast cancer cells in vivo显示文摘Barok M Tanner M Koninki K 0,,:1
5New catalytic matedals from amorphous metal alloys显示文摘MOLNAR S SMITH G V BAROK M 1989Adv Catal1989,36,:1
6Trastuzumab emtansine:mechanisms of action and drug resistance显示文摘Barok M Joensuu H Isola J 2014Breast Cancer Res2014,16,:1
7Trastuzumab-DM1 causes tumour growth inhibition by mitotic catastrophe in trastuzumab-resistant breast cancer cells in vivo显示文摘Barok M Tanner M Koninki K 0,,02:1
8Hyaluronan-induced masking of erbB2 and CD44-enhanced trastuzumab internalisation in trastuzumab resistant breast cancer显示文摘Pályi-Krekk Z Barok M Isola J 0,,16:1
9Trastuzumab-DM1 is highly effective in preclinical models of HER2-positive gastric cancer显示文摘Barok M Tanner M Ktininki K 2011Cancer Lett2011,306,2:1
10Trastuzumab emtansine:mechanisms of action and drug resistance 显示文摘BAROK M JOENSUU H ISOLA J 2014Breast Cancer Res2014,16,2:1
11Hyaluronan-induced masking of erbB2 and CD44-enhanced trastuzumab interualisation in trastuzumab resistant breast cancer显示文摘Pa1yi-Krekk Z Barok M lsola J 0,,:1
12Trastuzumab causes antibody dependent cellular eytotoxicity-mediated growth inhibition of submacroseopie JIMT-L breast cancer xenografts despitc intrinsic drug resistanee显示文摘Barok M IsolaJ Palyi Krekk Z 2007Mol Caneer Ther2007,6,7:1
13Die hard: are cancer stem ceils the Bruce Willises of tumor biology? 显示文摘FAbiAn A Barok M Vereb G 2009Cytometry A2009,75,1:1
14Trastuzumab-DM1 causes tumour growth inhibition by mitotic catastrophe in trastuzumab-resistant breast cancer cells in vivo显示文摘BAROK M TANNER M KNINKI K 2011Breast Cancer Res2011,13,2:1
15New catalytic materials from amorphous metal alloys 显示文摘Molnar S Smith G V Barok M 1989Adv Catal1989,36,:1
16Trastuzumab - DM1 causes tumour growth inhibition by mitotic catastrophe in tras- tuzumab - resistant breast cancer cells in vivo 显示文摘BAROK M TANNER M KONINKI K 2011Breast Cancer Res2011,13,2:1
17New catalytic materials from amorphous metal alloys显示文摘MOLNAR S SMITH G V BAROK M 1989Adv Catal1989,36,:1
18Trastuzumab-DM1 causes tumor growth inhibition by mitotic catastrophe in trastuzumab-resistant breast cancer ceils in vivo 显示文摘Barok M Tanner M Koninki K 2011Breast Cancer Res2011,13,2:1
19Trastuzumab -DM1 causes tumor growth inhibition by mitotic catastrophein trastuzumab - resistant breast cancer cells in vivo 显示文摘Barok M Tanner M Koninki K 2011Breast Cancer Res2011,13,2:1
20New treatment and markers of prognosis for idiopathic pulmonary fibrosis:lessons learned from translational research显示文摘Baroke E Gauldie J Kolb M 2013Expert Rev Respir Med2013,7,5:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费